NL Pharma SRL
NL Pharma reported total assets of 33,758 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Aug 2026).
The score of NL Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -90 % Total assets -61 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NL Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 20 Sep 2022
NL Pharma's financial analysis
- Solvency13.3%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NL Pharma
NL Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0661.907.808
- VAT number
- BE0661907808
- Peppol
- Registered · 0208:0661907808 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Sep 2016
- Registered office
- 5620 Florennes
- Latest accounts
- 2025 · filed on 24 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
NL Pharma (SRL) has been based in Florennes since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 1,457 € and equity of 4,488 €; its revenue is not published. Its solvency stands at 13.3%, below the median of its sector (41.5%).
Companies similar to NL Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- Pharmavanty Retail sale of pharmaceutical products Ninove · balance sheet 34,846 €
- VENI Retail sale of pharmaceutical products Meise · balance sheet 32,367 €
- Lorena Boulanger Pharma Retail sale of pharmaceutical products Chapelle-lez-Herlaimont · balance sheet 32,165 €
- Taxapharm Retail sale of pharmaceutical products Waterloo · balance sheet 35,480 €
- Goed Aalter Retail sale of pharmaceutical products Anderlecht · balance sheet 31,881 €
- AB Society Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 31,595 €
- Apotheker Silke Christiaens Retail sale of pharmaceutical products Lennik · balance sheet 37,111 €
Frequently asked questions about NL Pharma
What is the revenue of NL Pharma?
NL Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of NL Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0661907808 for NL Pharma, if the company is VAT-registered. Its company number (CBE) is 0661.907.808.
Where is the registered office of NL Pharma?
According to the CBE register, the registered office of NL Pharma is in 5620 Florennes.
What is the equity of NL Pharma?
At the close of the 2025 financial year, the equity of NL Pharma amounts to 4,488 €, a solvency of 13.3% of total assets.
Who manages NL Pharma?
The register lists 1 active mandates at NL Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NL Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →